Topics
High-grade gliomas | Treatment | Clinical trials | Margins
Home > Publications > Topics > High-grade gliomas > Treatment > Clinical trials > Margins
Qiu Y, Li Y, Cuihong J, Wu X, Liu W, Fan C, Ye X, He L, Xiao S,
Zhao Q, Wu W, Chen K, Tan C, Li Y, Wang H, Liu F.
Toxicity
and Efficacy of Different Target Volume Delineations of
Radiotherapy Based on the Updated RTOG/NRG and EORTC Guidelines in
Patients with Grade 3-4 Glioma: A Randomized Controlled Clinical
Trial.
Int
J Radiat Oncol Biol Phys. 2024 Nov
28:S0360-3016(24)03668-X. doi:
10.1016/j.ijrobp.2024.11.094. PMID:
39615657. Interventional study˰
ˍ
Zhong L, Zhou P, Chen L, Chen D, Wen L, Diao X, Zhang A, Gao Y, Chen G, Li X, Huang S, Niu K, Pei Y, Liu G, Lv S, Li G. Modified Target Delineation and Moderately Hypofractionated Radiotherapy for High-Grade Glioma: A Randomized Clinical Trial. JAMA Netw Open. 2025 Jul 1;8(7):e2523053. doi: 10.1001/jamanetworkopen.2025.23053. PMID: 40705330. Interventional study. ˍ ChiCTR.org.cn ID: ChiCTR1800014396.
Anvari K, Javadinia SA, Fazilatpanah D, Esmaily H, Aledavood SA,
Shahidsales S, Ganjeifar B, Dayani M, Rabiei P.
Comparing
the Recurrence Patterns of Reduced-Margins vs. RTOG-Protocol in
Adjuvant Chemoradiation of High-Grade Gliomas: A Multicenter,
Open-Label, Randomized Controlled Trial.
Asian
Pac J Cancer Prev. 2026 Jun 18;27(6):2005-2013. doi:
10.31557/APJCP.2026.27.6.2005. PMID:
42345146. Trial
registration ID: IRCT20210215050367N1. ˍ